Abstract
Liver fibrosis, Glyco-biomarker, Glyco-diagnostics, Glycoprotein, Lectin
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
References for Section 18.1
Taniguchi N et al (2009) The second golden age of glycomics: from functional glycomics to clinical applications. J Proteome Res 8:425–426.
Turner GA (1992) N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 208:149–171.
Kagebayashi C et al (2009) Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 388:306–311.
Kuno A et al (2013) A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep 3:1065.
Ito K et al (2017) Serum WFA+-M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: a meta-analysis. J Gastroenterol Hepatol 32:1922–1930.
References for Section 18.2
Taketa K (1990) Alpha-fetoprotein: reevaluation in hepatology. Hepatology 12:1420–1432.
Noda K et al (1998) Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein. Hepatology 28:944–952.
Kuno A et al (2013) A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep 3:1065.
Wang Y et al (2015) Loss of α1,6-fucosyltransferase suppressed liver regeneration: implication of core fucose in the regulation of growth factor receptor-mediated cellular signaling. Sci Rep 5:8264.
Kamada Y et al (2015) A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Hepatology 62:1433–1443.
References for Section 18.3
Okuyama N et al (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118:2803–2808.
Nakano M et al (2008) Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int J Cancer 122:2301–2309.
Deguchi T et al (2010) Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer. Cancer Res 70:5259–5269.
Uozumi N et al (2010) Identification of a novel type of CA19-9 carrier in human bile and sera of cancer patients: an implication of the involvement in nonsecretory exocytosis. J Proteome Res 9:6345–6353.
Miyoshi E, Kamada Y (2016) Application of glycoscience to the early detection of pancreatic cancer. Cancer Sci 107:1357–1362.
References for Section 18.4
Nakayama J et al (1999) Expression cloning of a human α1,4-N-acetylglucosaminyltransferase that forms GlcNAcα1→4Galβ→R, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proc Natl Acad Sci U S A 96:8991–8996.
Kawakubo M et al (2004) Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305:1003–1006.
Karasawa F et al (2012) Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest 122:923–934.
Shiratsu K et al (2014) Loss of gastric gland mucin-specific O-glycan is significantly associated with progression of differentiated-type adenocarcinoma of the stomach. Cancer Sci 105:126–133.
Yamada S et al (2015) Reduced gland mucin-specific O-glycan in gastric atrophy: a possible risk factor for differentiated-type adenocarcinoma of the stomach. J Gastroenterol Hepatol 30:1478–1484.
References for Section 18.5
Ishikawa T et al (2017) An automated micro-total immunoassay system for measuring cancer-associated alpha2,3-linked Sialyl N-glycan-carrying prostate-specific antigen may improve the accuracy of prostate cancer diagnosis. Int J Mol Sci 18:pii: E470
Hagiwara K et al (2017) Wisteria floribunda agglutinin and its reactive-glycan-carrying prostate-specific antigen as a novel diagnostic and prognostic marker of prostate cancer. Int J Mol Sci 18:pii: E261
Tsui K-H et al (2008) Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis. Anticancer Res 28:1993–1999
Kojima Y et al (2015) Detection of Core2 beta-1,6-N-Acetylglucosaminyltransferase in post-digital rectal examination urine is a reliable Indicator for extracapsular extension of prostate cancer. PLoS One 10:e0138520
Bao X et al (2009) Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci U S A 106:12109–12114
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kuno, A., Miyoshi, E., Nakayama, J., Ohyama, C., Togayachi, A. (2019). Glycan Biomarkers for Cancer and Various Disease. In: Taniguchi, N., et al. Glycoscience: Basic Science to Applications. Springer, Singapore. https://doi.org/10.1007/978-981-13-5856-2_18
Download citation
DOI: https://doi.org/10.1007/978-981-13-5856-2_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-5855-5
Online ISBN: 978-981-13-5856-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)